FP33-WE-02 Efficacy of natalizumab in second-line therapy of relapsing remitting multiple sclerosis: results from a multi-center study in German speaking countries
N. Putzki, Y. Oezguer, M. Mäurer, S. Cursiefen, S. Kuckert, V. Limmroth, M. Maschke, B. TettenbornVolume:
285
Year:
2009
Language:
english
DOI:
10.1016/s0022-510x(09)70440-x
File:
PDF, 47 KB
english, 2009